Heterozygous alpha 1-antitrypsin phenotypes in patients with end stage liver disease.

@article{Eigenbrodt1997HeterozygousA1,
  title={Heterozygous alpha 1-antitrypsin phenotypes in patients with end stage liver disease.},
  author={Marsha L. Eigenbrodt and Timothy Mccashland and Robert M. Dy and Jonathan Robert Clark and John C. Galati},
  journal={The American journal of gastroenterology},
  year={1997},
  volume={92 4},
  pages={602-7}
}
OBJECTIVE The objective of the study was to determine the prevalence and associations of abnormal alpha1-antitrypsin phenotypes in Caucasian adults with end stage liver disease with particular emphasis on heterozygous phenotypes and disease from hepatitis C virus. METHODS All patients (788) with end stage liver disease considered for liver transplantation from July 1990 to June 1996 in a referral-based university hospital transplant center (University of Nebraska Medical Center, Omaha, NE… CONTINUE READING